I think it will be above $3.20.
More would be nicer but I will settle for this for now.
We still have to get back to the $4.32 level of late July.
Sentiment: Strong Buy
67 sites now.
BioTime, Inc. (NYSE MKT and TASE: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (“Cell Cure”) today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation for OpRegen®, a cell-based therapeutic product consisting of retinal pigment epithelial (RPE) cells designed to block the progression of the severe dry-form of age-related macular degeneration (AMD), a leading cause of blindness in an aging population.
Just wait till ASH
Chip will tell us soon.